nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Child Psychiatry"

 

Positive School Climate and Suicidality Among LGBTQ Youth
June 9, 2021   

Suicide has been increasing in the adolescent population and most particularly among lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) youth. Stigma and discrimination towards sexual and gender minorities are thought to increase depressive symptoms that may in turn bring about suicidality. Given the ...
 Continue reading (Members only)
Childhood Exposure to Air Pollution Linked to Psychiatric Symptoms in Young Adulthood
May 18, 2021   

Emerging evidence shows that air pollution can directly and indirectly harm the central nervous system. Recent results from the Environmental-Risk Longitudinal Twin Study reported on the association between air pollution and the development of psychopathology in a population-based cohort of...
 Continue reading (Members only)
Association Between Gender-Affirming Surgery and Improved Mental Health
May 10, 2021   

Gender-affirming surgery refers to any surgical procedures offered to affirm the gender identities of transgender and gender diverse people. Evidence supporting a positive effect of gender-affirming surgeries on mental health is largely derived from low-quality studies. A secondary analysis of the...
 Continue reading
Disturbed Sleep and Depression in Children and Youths
April 9, 2021   

In a recently published meta-analysis, the relationship between disturbed sleep and depression was examined. A total of 22 studies were included in the study, of which 16 were included in the meta-analysis. Disturbed sleep was...
 Continue reading (Members only)
High-Risk Youth Population Are Not Receiving Behavioral Health Services
April 6, 2021   

Literature on pediatric mental health has suggested that adverse children’s experiences have been widespread and have gone unaddressed or untreated. A recent cross-sectional study was conducted to estimate the proportion of children with high levels of adverse children’s experiences or mental health symptoms who have not been receiving services from behavioral health professionals...
 Continue reading (Members only)
FDA Approves New Treatment For ADHD In Pediatric Patients
April 2, 2021   

A U.S. Food and Drug Administration approves viloxazine extended-release capsules for the treatment of attention-deficit hyperactivity disorder in pediatric patients 6 to 17 years of age...
 Continue reading
Ketamine for Adolescents With Treatment-Resistant Depression
March 23, 2021   

The glutamatergic agent, ketamine, has been increasingly studied and shown to have great benefit in adults with major depressive disorder but has not been as thoroughly examined in children and adolescents. In this study...
 Continue reading (Members only)
Youth With ADHD May Have Increased Risk for Psychotic Disorders
March 8, 2021   

In a recent meta-analysis of 12 studies and 1.85 million participants, an increased risk of psychotic disorder was associated with a diagnosis of attention deficit hyperactivity disorder during childhood compared to participants without attention deficit hyperactivity disorder during childhood....
 Continue reading
Positive Topline Results for Novel Autism Drug
March 1, 2021   

Autism spectrum disorder can be highly debilitating with issues in communication, socialization, and repetitive behaviors. Unfortunately, there is little available in the way of treatment. Exciting results from a Phase II clinical study conducted by...
 Continue reading (Members only)
Children With Congenital Heart Disease at Elevated Risk of Depression, Anxiety, ADHD
January 26, 2021   

A recent comparative cross-sectional study was conducted to examine the risk of mental health disorders (e.g. depression, anxiety, and attention deficit/hyperactivity disorder) in youth with congenital heart disease (CHD). Data was collected from...
 Continue reading (Members only)
1234567
Top of Page